4.5 Article

A Comprehensive Landscape of De Novo Malignancy After Double Lung Transplantation

Related references

Note: Only part of the references are listed.
Article Oncology

Cancer risk and mortality after solid organ transplantation: A population-based 30-year cohort study in Finland

Terhi Kristiina Friman et al.

Summary: Cancer is a significant cause of mortality among solid organ transplant recipients, with nonmelanoma skin cancers, non-Hodgkin lymphoma, and kidney cancer being the most common types. The incidence of cancer has decreased in recent years, possibly due to changes in immunosuppression methods.

INTERNATIONAL JOURNAL OF CANCER (2022)

Review Cardiac & Cardiovascular Systems

Post-transplant Lymphoproliferative Disorder Following Cardiac Transplantation

Rabea Asleh et al.

Summary: Post-transplant lymphoproliferative disorder (PTLD) is a spectrum of lymphoid conditions associated with Epstein Barr Virus (EBV) and immunosuppressive drugs. It remains a major cause of morbidity and mortality after heart transplantation. EBV is a key driver in many PTLD cases, with B-cell proliferation and impaired T-cell immune surveillance playing a crucial role. This article reviews the pathogenesis, recent advances, and potential therapeutic targets to reduce the burden of PTLD after heart transplantation.

FRONTIERS IN CARDIOVASCULAR MEDICINE (2022)

Article Surgery

OPTN/SRTR 2020 Annual Data Report: Lung

M. Valapour et al.

Summary: In 2020, there was a decrease in the number of lung transplants performed and candidates added to the waiting list, along with a decline in lung donors. This can be attributed to the impact of the global COVID-19 pandemic. However, the median time to transplant continued to decrease and posttransplant survival rates remained stable.

AMERICAN JOURNAL OF TRANSPLANTATION (2022)

Editorial Material Surgery

OPTN/SRTR 2020 Annual Data Report: Introduction

A. K. Lsrani

AMERICAN JOURNAL OF TRANSPLANTATION (2022)

Review Oncology

Immunosuppressive cells in cancer: mechanisms and potential therapeutic targets

Yan Tie et al.

Summary: Immunotherapies are effective for treating advanced cancers, but some patients are resistant to these therapies. Targeting immunosuppressive cells and related signals is a promising strategy to enhance the efficacy of immunotherapies.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2022)

Review Pharmacology & Pharmacy

Immunosuppression trends in solid organ transplantation: The future of individualization, monitoring, and management

Nicole A. Pilch et al.

Summary: The evolution of immunosuppression regimens in solid organ transplants in the United States over the past 70 years has been marked by significant advancements but also ongoing challenges in achieving the optimal balance between under- and overimmunosuppression. The development of effective regimens has been limited by factors such as the limited number of agents, early stages of HLA matching techniques, and lack of understanding of immunoreactivity. Future directions in transplant immunosuppression aim to move towards patient-specific optimization for optimal long-term outcomes.

PHARMACOTHERAPY (2021)

Editorial Material Medicine, General & Internal

Immortal Time Bias in Observational Studies

Kabir Yadav et al.

Summary: This article explains immortal time bias, which is an error that can occur when estimating the association between exposure and outcome, and presents approaches to minimize or avoid this bias.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Review Immunology

Harnessing Mechanisms of Immune Tolerance to Improve Outcomes in Solid Organ Transplantation: A Review

Priscila Ferreira Slepicka et al.

Summary: This article discusses the conventional and unconventional immunological mechanisms underlying the development of immune tolerance in solid organ transplant (SOT) recipients, as well as how these mechanisms can inform clinical progress. Specifically, recent mechanistic studies elucidating the role of regulatory cells in dampening cytotoxic immune reactivity and fostering a tolerogenic environment are reviewed. The understanding of regulatory cells can shape graft engineering and other therapeutic strategies to improve long-term outcomes for patients receiving hematopoietic stem cell transplantation (HSCT) and SOT.

FRONTIERS IN IMMUNOLOGY (2021)

Review Oncology

Cutaneous squamous cell carcinoma in the organ transplant recipient

Kristin Bibee et al.

ORAL ONCOLOGY (2020)

Review Biochemistry & Molecular Biology

Idiopathic Pulmonary Fibrosis and Lung Cancer: Mechanisms and Molecular Targets

Beatriz Ballester et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Editorial Material Cardiac & Cardiovascular Systems

Outcomes in Solid-Organ Transplantation: Success and Stagnation

Abbas Rana et al.

TEXAS HEART INSTITUTE JOURNAL (2019)

Review Dermatology

Skin Cancer Following Solid Organ Transplantation: A Review of Risk Factors and Models of Care

Matthew D. Howard et al.

AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2018)

Article Cardiac & Cardiovascular Systems

Azathioprine to mycophenolate mofetil transition and risk of squamous cell carcinoma after lung transplantation

Martin Vos et al.

JOURNAL OF HEART AND LUNG TRANSPLANTATION (2018)

Review Oncology

The epidemiology of lung cancer

Patricia M. de Groot et al.

TRANSLATIONAL LUNG CANCER RESEARCH (2018)

Article Surgery

Risk Factors for De Novo Malignancy Following Lung Transplantation

J. T. Magruder et al.

AMERICAN JOURNAL OF TRANSPLANTATION (2017)

Article Dermatology

Effect of voriconazole on risk of nonmelanoma skin cancer after hematopoietic cell transplantation

Lawrence F. Kuklinski et al.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2017)

Article Urology & Nephrology

Immunosuppressive Medications

Alexander C. Wiseman

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)

Article Oncology

Risk of lymphoma subtypes after solid organ transplantation in the United States

C. A. Clarke et al.

BRITISH JOURNAL OF CANCER (2013)

Article Medicine, Research & Experimental

Cancer in the Transplant Recipient

Jeremy R. Chapman et al.

COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2013)

Article Geriatrics & Gerontology

Epidemiology and Management of Common Pulmonary Diseases in Older Persons

Kathleen M. Akguen et al.

JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2012)

Article Medicine, General & Internal

Spectrum of Cancer Risk Among US Solid Organ Transplant Recipients

Eric A. Engels et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)

Article Surgery

Trends in Organ Donation and Transplantation in the United States, 1999-2008

R. A. Wolfe et al.

AMERICAN JOURNAL OF TRANSPLANTATION (2010)

Article Allergy

Transplantation immunology: Solid organ and bone marrow

Javier Chinen et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2010)

Review Medicine, Research & Experimental

Antibody immunosuppressive therapy in solid-organ transplant Part I

Nadim Mahmud et al.

Article Pharmacology & Pharmacy

Immunosuppression for lung transplantation

Gregory I. Snell et al.

DRUGS (2007)

Review Immunology

Malignancy after transplantation

JF Buell et al.

TRANSPLANTATION (2005)

Review Oncology

Immunosuppressive agents in solid organ transplantation: Mechanisms of action and therapeutic efficacy

AL Taylor et al.

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2005)

Review Oncology

MTOR-targeted therapy of cancer with rapamycin derivatives

S Vignot et al.

ANNALS OF ONCOLOGY (2005)

Review Medicine, Research & Experimental

Post-transplant lymphoproliferative disorders

S Gottschalk et al.

ANNUAL REVIEW OF MEDICINE (2005)

Article Immunology

Use of cyclosporine in lung transplantation

K Parekh et al.

TRANSPLANTATION PROCEEDINGS (2004)

Article Surgery

Lymphomas after solid organ transplantation:: A collaborative transplant study report

G Opelz et al.

AMERICAN JOURNAL OF TRANSPLANTATION (2004)

Review Immunology

Cancer immunoediting: from immunosurveillance to tumor escape

GP Dunn et al.

NATURE IMMUNOLOGY (2002)

Article Dermatology

Incidence of skin cancer in 5356 patients following organ transplantation

B Lindelof et al.

BRITISH JOURNAL OF DERMATOLOGY (2000)